AHK-Cu

100mg Vial

2 September 2026Updated 2 September 2026

AHK-Cu

Overview Research1 Mechanism Protocols Safety

Discussions

This is Premium content Premium

Create a free account, then upgrade to Premium or Lifetime to unlock the full research article, mechanism of action, results timeline, dosing protocol, and dose calculator for AHK-Cu.

Create free account Member login

Full range of benefits for AHK-Cu

Supports collagen and extracellular matrix synthesis

Promotes fibroblast proliferation and migration

Enhances wound healing and re-epithelialization

Modulates inflammation and matrix metalloproteinase activity

Exhibits antioxidant and free-radical scavenging effects

Stimulates angiogenesis to support tissue repair

May support hair follicle health and growth signaling

Demonstrates antimicrobial activity against skin microbes in vitro

May improve skin firmness and elasticity via ECM remodeling

This peptide's combination-safety and interaction data below always stays visible, regardless of membership.

Warning

Important information. The data compiled from scientific literature is provided for educational purposes. Dosage ranges reflect what is reported in studies and do not constitute a recommendation, prescription, or usage guidance. Health decisions should always be made with a qualified professional.

Peptide Interactions

// 20 known interactions

Synergistic(5)Compatible(5)Monitor(5)Avoid(5)

Works exceptionally well with this peptide

Ascorbic acid (Vitamin C)

Vitamin C supports collagen synthesis and can enhance AHK-Cu–mediated dermal repair by providing necessary cofactor activity for collagen hydroxylation.

Topical retinoids (tretinoin, adapalene)

Retinoids promote epidermal turnover and dermal remodeling and may augment peptide-driven collagen induction and skin rejuvenation.

Hyaluronic acid (topical or injectable)

Hyaluronic acid improves tissue hydration and matrix deposition, complementing AHK-Cu's wound‑healing and extracellular matrix effects.

Platelet‑rich plasma (PRP)

Growth factors in PRP synergize with copper peptide activity to accelerate tissue repair and angiogenesis in localized treatments.

Low‑level laser therapy (photobiomodulation)

Photobiomodulation stimulates cellular metabolism and can enhance peptide‑mediated regenerative responses in treated tissues.

All interaction categories

Synergistic (5)

Ascorbic acid (Vitamin C): Vitamin C supports collagen synthesis and can enhance AHK-Cu–mediated dermal repair by providing necessary cofactor activity for collagen hydroxylation.
Topical retinoids (tretinoin, adapalene): Retinoids promote epidermal turnover and dermal remodeling and may augment peptide-driven collagen induction and skin rejuvenation.
Hyaluronic acid (topical or injectable): Hyaluronic acid improves tissue hydration and matrix deposition, complementing AHK-Cu's wound‑healing and extracellular matrix effects.
Platelet‑rich plasma (PRP): Growth factors in PRP synergize with copper peptide activity to accelerate tissue repair and angiogenesis in localized treatments.
Low‑level laser therapy (photobiomodulation): Photobiomodulation stimulates cellular metabolism and can enhance peptide‑mediated regenerative responses in treated tissues.

Compatible (5)

Topical emollients (ceramide/moisturizer formulations): Emollients are neutral and supportive of barrier restoration without interfering with AHK-Cu activity.
Broad‑spectrum sunscreen (SPF preparations): Sunscreens are compatible and recommended to protect treated skin from UV damage during peptide therapy.
Topical antibiotics for local infection control (e.g., mupirocin): Topical antibacterial agents can be used concurrently to manage local infection without known antagonism to AHK-Cu.
Non‑metallic wound dressings (silicone sheets, hydrocolloids): Standard non‑metallic dressings are compatible and provide a protective environment for peptide‑treated wounds.
Physical rehabilitation/therapeutic exercise: Adjunctive physical therapy is neutral and can support functional recovery without pharmacological interaction with the peptide.

Monitor (5)

Oral copper supplements (copper gluconate, copper sulfate): Co‑administration can increase systemic copper exposure so monitor serum copper and ceruloplasmin to avoid overload.
High‑dose zinc supplements: Excess zinc can impair copper absorption and reduce AHK‑Cu efficacy, so monitor zinc/copper balance and adjust dosing as needed.
Copper chelators (penicillamine, trientine): Chelating agents reduce bioavailable copper and may antagonize AHK‑Cu effects, necessitating monitoring of clinical response and copper indices.
Systemic corticosteroids: Steroids impair wound healing and immune response so monitor healing progress and infection markers if used concurrently.
Renal function assessment (serum creatinine/eGFR): Altered renal function can change systemic handling of trace metals and adjunctive drugs, so monitor renal indices when systemic copper exposure is possible.

Avoid (5)

High‑dose zinc supplementation: High zinc doses may antagonize copper uptake and reduce peptide efficacy, so carefully evaluate indication and timing relative to AHK‑Cu therapy.
Copper‑containing topical preparations/oxides: Concomitant topical copper products may increase local copper exposure and irritation, so assess cumulative topical copper load before combining.
Systemic copper chelators (penicillamine, trientine): Chelators can negate therapeutic effects of AHK‑Cu and should be avoided or justified with clear monitoring if co‑administration is necessary.
Topical retinoids (for patients with sensitive or actively inflamed skin): Although retinoids can be synergistic, they may increase local irritation in sensitive skin and should be used cautiously with gradual introduction and monitoring.
Systemic immunosuppressants (e.g., methotrexate, azathioprine): Immunosuppressants can impair tissue repair and increase infection risk, so evaluate risks and monitor healing closely before combining with regenerative peptide therapy.